Paratus Sciences Corporation
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $21M
Investors
- 6
About Paratus Sciences Corporation
Founded in 2021 and based in New York, US, Paratus Sciences Corporation uses research on bat biology to enhance human health and health security. As of March 2023, Amir Nashat serves as the CEO of the company. The company delivers a therapeutic discovery platform that focuses on identifying and developing new medicines for a wide range of disorders by unlocking the bat genome. The firm’s biology approach includes deep sequencing, bioinformatics and machine learning, protein structure prediction, stem cells, protein-protein interaction mapping, bat antibody libraries, comparative genetics, and animal models.
Who invested in Paratus Sciences Corporation
6 investors across 1 round
See all investors in Paratus Sciences Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 27, 2023
Amount
$21M
Investors
Questions about Paratus Sciences Corporation
Who invested in Paratus Sciences Corporation?
Paratus Sciences Corporation has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Paratus Sciences Corporation raised?
Paratus Sciences Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Paratus Sciences Corporation last raise money?
Paratus Sciences Corporation's most recent round on record is a Series A, in Feb 2023.
What does Paratus Sciences Corporation do?
Founded in 2021 and based in New York, US, Paratus Sciences Corporation uses research on bat biology to enhance human health and health security.
Where is Paratus Sciences Corporation headquartered?
Paratus Sciences Corporation is headquartered in New York, US.
Which VCs invest in companies like Paratus Sciences Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Paratus Sciences Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Paratus Sciences Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.